Mangoceuticals Inc (MGRX) Stock: A Year of Highs and Lows in the Market

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Mangoceuticals Inc’s current trading price is -91.45% away from its 52-week high, while its distance from the 52-week low is 45.94%. The stock’s price range for this time frame has been between $0.26 and $4.37. The trading volume of the company’s shares in the Healthcare reached around 760.37 for the day, which was evidently higher than the average daily volume of 1.18 over the last three months.

How Financial Performance Impacts Market Capitalization

Mangoceuticals Inc (MGRX) has experienced a quarterly decline of -26.75% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 8.23M.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.5459, with a change in price of -0.6164. Similarly, Mangoceuticals Inc recorded 627,845 in trading volume during the last 100 days, posting a change of -62.26%.

How MGRX’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for MGRX stands at 0.10. Similarly, the long-term debt-to-equity ratio is also 0.06.

MGRX Stock Stochastic Average

The raw stochastic average for Mangoceuticals Inc over the last 50 days is presently at 17.98%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 49.82%. Further, the company’s Stochastic %K and %D values for the last 20 days were 57.87% and 64.87%, respectively.

MGRX Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Until today this year the stock’s price performance recorded an increase of 34.92%. However, over the last six months, the performance has been stronger by -71.04%. The price of MGRX increased 16.75% over the last 30 days. And in the last five days, it has fallen by -15.26%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts